LCM
NBIX icon

Landscape Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Landscape Capital Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
+9,616
New +$1.43M 0.11% 311
2024
Q4 		– Sell
-8,684
Closed -$1M – 849
2024
Q3 		$1M Buy
+8,684
New +$1.19M 0.1% 266
2019
Q4 		– Sell
-2,389
Closed -$215K – 766
2019
Q3 		$215K Buy
+2,389
New +$223K 0.02% 585
2017
Q2 		– Sell
-10,940
Closed -$423K – 402
2017
Q1 		$423K Hold
10,940
– – 0.04% 338
2016
Q4 		$423K Buy
+10,940
New +$495K 0.06% 346

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Landscape Capital Management's NBIX Position: Q2 2026 in Review

Landscape Capital Management opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 9,616 shares worth $1.62M. The stake represents 0.11% of the portfolio and ranks #311 among its holdings. This is a return to the name: Landscape Capital Management previously reported a position in NBIX as recently as Q3 2024.

Landscape Capital Management first reported a position in NBIX in Q4 2016 and has held it in 5 quarters since. 779 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Landscape Capital Management held 9,616 shares of Neurocrine Biosciences worth $1.62M as of Q2 2026.
  • Neurocrine Biosciences was a new Landscape Capital Management position in Q2 2026.
  • Neurocrine Biosciences made up 0.11% of Landscape Capital Management's portfolio in Q2 2026, its #311 holding.
  • Landscape Capital Management first reported a position in Neurocrine Biosciences in Q4 2016 and has held it in 5 quarters since.
  • 779 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.